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Abstract: Anxiety sindrome appears in dogs at any age if in the first life time period affective trauma 
affected them. In owner absence dogs may panic , reacting with destructive behaviour ,sometimes urinating in 
forbiden areas , hiperactivity or deep depression , anorexia and sometimes aaggression to the owner. Base 
characteristic of this syndrome shows that clinical signs starts immediately or after a short time after owner 
leaving.  
 
INTRODUCTION 
 
Paper proposal is to establish an intervention protocol for separation anxiety therapy which 
based on proper selection methods , prevention , training and than medical products administration.  
We tried to establish a relation between cortisol and testosterone levels and clinical signs.  
 
MATERIAL AND METHOD 
 
In our studied cases for anxiety separation syndrome diagnosis we used basic semiologic 
methods, major importance having the anamnetic dates and contact owner-dog observations.   
Five dogs with different breeds , sex and ages were included in our study. Methods used for 
behaviour correction were :training , different games and finally medical therapy. Each case was 
examined to eliminate other causes wich could cause behavioural changes. 
Medical product used was fluoxetina (Prozac , Lilly S.A Spain and Fluoxin , Romanian product 
, both with 20mg a.s/tablet) which produce a  selective serotonine reabsorbtion inhibition.  
Two dogs were treated with Fluoxin 0,5mg/kg/day in the morning and three dogs with Prozac 
0.5 mg/kg/day. At the beginnigg of the experiment dogs received half dose (medication being used in 
human medicine) and than recomanded dose 1mg/kg/day was use. 
Every hour , heart rate , body temperature , breath rate , and behavioural aspects were studied 
before and after medical administrations .Before and after medication , blood samples were taken to 
determine biochemical and hematological parameters. 
For hematological determinations automatic analyzer produced by Diatron Ltd, USA was used.  
For biochemical determinations an automatic analyzer produced by Awareness Technology, USA was 
used, which needs specific reactives for every parameter.  
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Blood samples (3ml) were taken on EDTA for hematology determinations and for biochemical 
and hormonal determinations blood samples (6ml) were taken . Ca , Mg. , P , cortisol and testosterone 
determinations were studied. Blood samples were taken three hours after medical ingestion.  
             
RESULTS AND DISCUSION 
 
Relevant cases are presented: 
 
  Lot I: Fluoxin administration 0.5 mg/kc/zi, per os. 
 Case I :     
  Species: canine;  
  Breed: common;  
  Age: 3 years old;  
  Sex: male;  
  Body weight: 11.6 kg;  
  Colour: brown with white spots;   
  Anamnetic dates: barking and crying when owner misses, hyperactivity, happiness 
when owner comes back. 
      
Values obtained from blood samples before medical administration (table 1) 
 
Table 1. Blood samples values before medical 
 
Results obtained at hematological determinations :  
 
Medical product was diluted in water and 5.8 mg respectively 2.9 ml of  the medical dilution 
was used.  
 Biochemical determinations from blood samples after medical administration :  
(table 2) 
 
 
Table 2 Biochemical determinations from blood samples after medical administration 
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 Hematological determinations: 
 
 
 
                       
 Lot II:  Prozac administration, 0,5 mg/kc/day, per os 
 Case V: 
  Specie: canine      
  Breed: Métis 
  Age: 1,5 years old 
  Body weight: 9,3 kg 
  Sex: male 
  Colour: yellow 
  Anamnesis dates: excessive chewing of owner objects,  
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TEST REZULTAT UNITATE MIN MAX OBS. 
CA TOTAL 4.52 mEq/l 4.5 10  
MG 1.51 mEq/l 1.5 4  
FOSFOR 2.92 mg/dl 2.9 6.2  
CORTISOL 18 ng/ml 5 60  
TESTOSTERON 2.40 ng/ml 0.5 9.00  
 
Tabel 3. Biochemical blood values before medical ingestion 
 
   
         TEST RESULT   
UNIT 
     
MIN 
    
MAX 
  
OBS. 
CA TOTAL 4.31      
mEq/l 
4.5       
10 
 
MG 1.39      
mEq/l 
1.5        
4 
 
FOSFOR 3.20      
mg/dl 
2.9       
6.2 
 
CORTISOL 61.30      
ng/ml 
5       
60 
 
TESTOSTERON 2.10      
ng/ml 
0.5      
9.00 
 
 
Tabel 4. Blood biochemical values obtained after medical ingestion. 
 
CONCLUSION 
 
Separation anxiety syndrome have a complex etiology ; that’s why  single medical therapy is not 
effective being necessary also prevention and selection methods to be applied . Playing and training 
methods are very important decreasing the physical impact to the animal .. 
Major role in behavioral changes prevention is the primary socialization  and adoption moment . 
Prozac and Fluoxin therapy doesn’t produce major changes being selective serotonins 
reabsorbing inhibitors.  
 Fluoxin therapy  induce :  
decreasing heart and breath rates ,body temperature remaining constant  
total white blood cells number remain normal , neutropenia, increasing number of eosinophiles  
 Prozac therapy induce :  
breath and heart rates decrease to the minimal normal limit  
total leucocytes remain in normal values, eozinophilic, neutrophilic number increase,  
             None of the cases presented side effects to the medicines . 
             Based on our results we recommend the two products Prozac and Fluoxin in anxiety  
separation syndrome therapy. 
             At  the beginning of the treatment low doses have to be used and increased doses must 
be used based on animal response. That’s how we can establish the perfect dose for each dog.  
 
 
 
 231 
 
BIBLIOGRAPHY 
 
1. Beata. C., 1998, L'attachement: racine de l'équilibre et de la pathologie comportementale, Ecoles 
Nationales  Vétérinaires Françaises, Mémoire pour le diplôme de Vétérinaire 
Comportementaliste. 
2. Carter AP, C. Chen, PM Scwartz, RA Segal, 2002, Brain-derived neurotrophic factor modulates cerebellar 
plasticity an synaptic ultra-structure. 
3. Coman I., Podoleanu L., Gaşpar C., 2003‚ Etologie şi eredopatologie, Iaşi Ed. Tehnopress. 
4. Decun M., 2004, Etologia, bunăstarea şi protecŃia animalelor, Timişoara, Ed. Mirton. 
5. Do-Rego. J.C., et al., 2002, Mouse lines differing in sensitivity to beta-CCM differ in tasks used for 
testing antidepressants. 
6. King. J.N., et al., 2000, Treatment of separation anxiety in dogs with clomipramine: results from a 
prospective, randomized, double-blind, placebo-controlled, parallel-group, multicenter clinical trial.  
7. May. F.,  2003, L'attachement chez le chien, Ecoles Nationales Vétérinaires Françaises, Mémoire pour le 
Diplome de Vétérinaire Comportementaliste. 
 
 
      
 
 
 
 
 
 
 
 
 
 
